Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma

Bone Marrow Transplantation

Volumn 19, Issue 6, 1997, Pages 553-556

  Kimlinger, T ^a   Witzig, T E ^a  

^a MAYO CLINIC   (United States)

Author keywords

CD34; Multiple myeloma; Stem cell transplants

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN;

ARTICLE; BLOOD CELL; BLOOD DISEASE; BONE MARROW CELL; CELL SELECTION; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TUMOR CELL;

EID: 0030890414     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700697     Document Type: Article

References (31)

1. Berenson I, Wong R, Kim K et al. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550-1553.
2. Witzig T, Dhodapkar M, Kyle R, Greipp P. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993; 72: 108-113.
3. Billadeau D, Quam L, Thomas W et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818-1824.
4. Witzig T, Gertz M, Pineda A et al. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol 1995; 89: 640-642.
5. Mariette X, Fermand J-P, Brouet J-C. Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant 1994; 14: 47-50.
6. Vora A, Toh C, Peel J, Greaves M. Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration. Br J Haematol 1994; 86: 180-182.
7. Corradini P, Voena C, Astolfi M et al. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995; 85: 1596-1602.
8. Dreyfus F, Ribrag V, Leblond V et al. Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma. Bone Marrow Transplant 1995; 15: 707-711.
9. + stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381-389.
10. Bird J, Bloxham D, Samson D et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma. Br J Haematol 1994; 88: 110-116.
11. + B cell precursors. Stem Cells 1994; 12: 95-102.
12. + hematopoietic cells using an immunoaffinity column results in T cell depletion equivalent to elutriation. Exp Hematol 1995; 23: 320-322.
13. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
14. Krause D, Fackler M, May W. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
15. Shpall E, Jones R, Bearman S et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
16. Bensinger W, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
17. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
18. Vescio R, Hong C, Cao J et al. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283-3290.
19. Takashita M, Kosaka M, Goto T, Saito S. Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. Br J Haematol 1994; 87: 735-742.
20. Kawano M, Huang N, Harada H et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993; 82: 564-570.
21. Hata H, Xiao H, Petrucci M et al. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 1993; 81: 3357-3364.
22. Westendorf J, Ahmann G, Armitage R et al. CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 1994; 152: 117-128.
23. Witzig T, Kimlinger T, Ahmann G et al. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996; 26: 113-120.
24. Harousseau J-L, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French registry on autologous transplantation in multiple myeloma. Blood 1995; 85: 3077-3085.
25. Gertz M, Pineda A, Chen M et al. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am J Med Sci 1995; 309: 152-161.
26. Jagannath S, Barlogie B, Dicke K et al. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
27. Dimopoulos M, Alexanian R, Przepiorka D et al. Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324-2328.
28. Fermand J-P, Chevret S, Ravaud P et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
29. Witzig T, Gertz M, Lust J et al. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leuk Lymphoma 1995; 19: 417-422.
30. Gertz M, Witzig T, Pineda A et al. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation Bone Marrow Transplant 1997; 19: 337-342.
31. Dunbar C, Cottler-Fox M, O'Shaughnessy J et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.